THE INTERACTIONS BETWEEN SLEEP DISORDERED BREATHING, METABOLIC SYNDROME AND VASCULAR RISK

The effect of 4 months of CPAP treatment on cardiovascular risk factors in subjects with metabolic syndrome and obstructive sleep apnoea

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000083695

Acronym

Metabolic Sleep Study

Enrollment

150

Registered

2005-08-05

Start date

2004-01-06

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

4 months CPAP treatment

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

subjects with metabolic syndrome and no known sleep disorders

Exclusion criteria

No exclusion criteria

Outcome results